ARK Genomic Revolution ETF vs Liberty Global Ltd Class C — how do they compare? ARK Genomic Revolution ETF trades at $44.45, while Liberty Global Ltd Class C trades at $10.09 (market cap $3.48B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Liberty Global Ltd Class C nearer its low. Which is the better fit depends on your goals.
| ARKG | LBTYK | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $12.67 |
52-Week Low | $24.02 | $9.59 |
Market Cap | — | $3.48B |
Enterprise Value | — | $10.13B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LBTYK trades at $10.015, up 0.25% on the day, amid a bearish technical signal but strong analyst support. The stock shows mixed earnings, with a Q1 2026 beat but Q4 2025 and Q2 2026 misses, while the company navigates the Ziggo Group spin-off planned for 2027. Financially, it has a low P/S of 0.7 and P/B of 0.37, but negative net income and ROE highlight profitability challenges, offset by solid operating cash flow of $1.21 billion in 2025.
The outlook is cautiously optimistic, with the Ziggo Group listing in 2027 offering a potential catalyst, but persistent losses and competitive pressures pose risks. Analyst consensus is strongly bullish with 69% buy ratings, suggesting underlying value despite near-term headwinds.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →